Author

Khalil Saadipour

PTC Therapeutics (United States)ORCID 0000-0001-6366-5980Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:multiome· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Angela Minnella· 1 shared Christie MorrilliD· 1 shared Christopher R. TrottaiD· 1 shared Elisabetta MoriniiD· 1 shared Ellen M. WelchiD· 1 shared Hannah Lindmeier· 1 shared Jana NarasimhaniD· 1 shared Jeffrey K. TrimmeriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Angela Minnella

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MAPT Splicing Modulators as a Therapeutic Strategy for Tauopathies

M. Catarina Silva, Hannah Lindmeier, Paolo Pigini, Jennifer Laughlin, Yong Yu, Christie Morrill, Michael A. Arnold, Scott J. Barraza, Khalil Saadipour, Monal Dieterich, Angela Minnella, Kausiki Datta, Nanjing Zhang, Jana Narasimhan, Christopher R. Trotta, , Elisabetta Morini

Discovery of SMCs that correct MAPT splicing, reduce 4R tau, and rescue pathology in patient-derived neuronal and in vivo models of 4R tauopathies.

bioRxiv · May 6, 2025 · PreprintNeuroscience